Austen B. Helfrich
CIK: 0002039887
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Healthcare Realty Trust Inc
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jan 3, 2026HR
Healthcare Realty Trust Inc
Tax Payment(F)Direct664 shares at avg. $16.95$11K - Feb 28, 2025HR
Healthcare Realty Trust Inc
Award(A)Direct43.8K shares at avg. $17.13$750K - Feb 11, 2025HR
Healthcare Realty Trust Inc
Award(A)Direct27.8K shares at avg. $16.17$450K - Feb 10, 2025HR
Healthcare Realty Trust Inc
Tax Payment(F)Direct205 shares at avg. $16.27$3K - Jan 1, 2025HR
Healthcare Realty Trust Inc
Award(A)Direct4K shares at avg. $16.94$67K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 3, 2026 | HR Healthcare Realty Trust Inc | Tax Payment(F) | 664 | $16.95 | $11,255 | Direct |
| Feb 28, 2025 | HR Healthcare Realty Trust Inc | Award(A) | 43,782 | $17.13 | $749,986 | Direct |
| Feb 11, 2025 | HR Healthcare Realty Trust Inc | Award(A) | 27,829 | $16.17 | $449,995 | Direct |
| Feb 10, 2025 | HR Healthcare Realty Trust Inc | Tax Payment(F) | 205 | $16.27 | $3,335 | Direct |
| Jan 1, 2025 | HR Healthcare Realty Trust Inc | Award(A) | 3,984 | $16.94 | $67,489 | Direct |
1-5 of 5 transactions
About Helfrich Austen B.
Helfrich Austen B. (SEC CIK 0002039887) files insider reports with the SEC as EVP and CFO of Healthcare Realty Trust Inc (HR).
Signal8 holds 5 ownership filings by Helfrich Austen B. (1 Form 3, 4 Form 4), filed between Oct 7, 2024 and Jan 5, 2026. Those filings report 5 transactions, from Jan 1, 2025 to Jan 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Helfrich Austen B.'s filings is in NASHVILLE, TN.
Recent filings by Helfrich Austen B.
Other insiders filing for Healthcare Realty Trust Inc (HR)
- Hull Robert E, EVP and COO
- Callaway Amanda L, SVP & Chief Accounting Officer
- Bohjalian Thomas N, Director
- HENRY DAVID, Director
- MOORE CONSTANCE B, Interim President and CEO
- RUFRANO GLENN J, Director